CHOLANGIOCARCINOMA RESECTABLE

Clinical trials for CHOLANGIOCARCINOMA RESECTABLE explained in plain language.

Never miss a new study

Get alerted when new CHOLANGIOCARCINOMA RESECTABLE trials appear

Sign up with your email to follow new studies for CHOLANGIOCARCINOMA RESECTABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

Donor immune cells tested to stop deadly cancers from returning

Disease control Recruiting now

This study is testing whether adding donor immune cells (called NK cells) to standard chemotherapy helps prevent cancer from coming back after surgery. It will involve about 42 adults with pancreatic or bile duct cancer who have had their tumor surgically removed. The research fi…

Matched conditions: CHOLANGIOCARCINOMA RESECTABLE

Phase: PHASE1, PHASE2 • Sponsor: Medigen Biotechnology Corporation • Aim: Disease control

Last updated Apr 01, 2026 21:41 UTC

CHOLANGIOCARCINOMA RESECTABLE

Get alerted when new CHOLANGIOCARCINOMA RESECTABLE trials appear

Donor immune cells tested to stop deadly cancers from returning